Robin Steele

Robin Joan Steele is currently Director at Nacuity Pharmaceuticals, Inc. since 2020, Director at Ancient Organics Bioscience, Inc. since 2019, Director at Alveo Technologies, Inc., Independent Director at Daré Bioscience, Inc. since 2017, and Director at Gladiator Biosciences, Inc. Former roles include Director at Alios BioPharma, Inc., Director at Targanta Therapeutics Corp.
from 2005 to 2007, Director at Ocuterra Therapeutics, Inc. from 2021 to 2024, Director at Coagulant Therapeutics, Inc. from 2021 to 2024, Secretary, Senior VP & General Counsel at InterMune, Inc. from 2012 to 2014, and Vice President-Commercial & Legal Affairs at Elan Pharmaceuticals LLC from 1998 to 2003.
Education includes undergraduate studies at The University of Colorado, graduate studies at the University of California, Hastings, and graduate studies at New York University School of Law.